The effectiveness allows Yorkville to begin reselling shares immediately, creating near-term selling pressure. Monitor for subsequent resale filings and any updates on the strategic alternatives process, which could include a sale or reverse merger.
Price Chart
Executive Summary
BioAtla's S-1 registration statement (File No. 333-299532) became effective on October 29, 2026, enabling the resale of up to 8,182,110 shares by Yorkville under the Standby Equity Purchase Agreement. This removes a key regulatory hurdle for the company's equity line, which is critical given its $1.5M cash balance and going concern warning.
Key Facts
- Effectiveness date: October 29, 2026
- Registration covers resale of up to 8,182,110 shares by YA II PN, Ltd. (Yorkville)
- SEPA allows BioAtla to sell up to $40M of common stock to Yorkville over 36 months at a 3% VWAP discount
- BioAtla had only $1.5M cash as of June 30, 2026
- Company has substantial doubt about going concern and is pursuing strategic alternatives
- Market cap is approximately $3M
Financial Impact
Potential dilution of up to 8.18M shares (likely exceeding current outstanding shares given $3M market cap) and up to $40M in equity line capacity
Risk Factors
- Immediate dilution risk as Yorkville can now resell shares into the market
- Going concern risk remains acute with only $1.5M cash and no approved products
- Strategic alternatives process may result in unfavorable terms or no deal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003378 |
| Document: 9999999995-26-003378-index.html | 9999999995-26-003378 |
| Document: 9999999995-26-003378.txt | 9999999995-26-003378 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | EFFECT | $1.59 | awaiting T+20 | awaiting T+20 | $2.10 (−32.08%) |
Oct 19, 2026 12d ago | S-1 | $1.74 | awaiting T+20 | awaiting T+20 | $2.10 (−21.04%) |
Oct 19, 2026 12d ago | 8-K | $1.74 | awaiting T+20 | awaiting T+20 | $2.10 (−21.04%) |
Aug 28, 2026 9w ago | 8-K | $1.74 $1.74 | · 0.00% | ▲ +0.26% | $2.10 (−21.04%) |
Mar 31, 2026 30w ago | 8-K | $6.75 $4.04 | ▲ +40.15% | ▲ +49.87% | $2.10 (+68.89%) |
Mar 2, 2026 34w ago | DEFA14A | $10.20 $7.70 | ▼ −24.51% | ▼ −16.57% | $2.10 (−79.41%) |
Mar 2, 2026 34w ago | Press Release | $10.20 $7.70 | ▲ +24.51% | ▲ +16.57% | $2.10 (+79.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers